Ultrasound-mediated cavitation shows great promise for improving targeted drug delivery across a range of clinical applications. Cavitation nuclei—sound-sensitive constructs that enhance cavitation activity at lower pressures—have become a powerful adjuvant to ultrasound-based treatments, and more recently emerged as a drug delivery vehicle in their own right. The unique combination of physical, biological, and chemical effects that occur around these structures, as well as their varied compositions and morphologies, make cavitation nuclei an attractive platform for creating delivery systems tuned to particular therapeutics. In this review, we describe the structure and function of cavitation nuclei, approaches to their functionalization and customization, various clinical applications, progress toward real-world translation, and future directions for the field.
In tissues and organs, the extracellular matrix (ECM) helps maintain inter- and intracellular architectures that sustain the structure–function relationships defining physiological homeostasis. Combining fiber scaffolds and cells to form engineered tissues is a means of replicating these relationships. Engineered tissues' fiber scaffolds are designed to mimic the topology and chemical composition of the ECM network. Here, we asked how cells found in the heart compare in their propensity to align their cytoskeleton and self-organize in response to topological cues in fibrous scaffolds. We studied cardiomyocytes, valvular interstitial cells, and vascular endothelial cells as they adapted their inter- and intracellular architectures to the extracellular space. We used focused rotary jet spinning to manufacture aligned fibrous scaffolds to mimic the length scale and three-dimensional (3D) nature of the native ECM in the muscular, valvular, and vascular tissues of the heart. The representative cardiovascular cell types were seeded onto fiber scaffolds and infiltrated the fibrous network. We measured different cell types' propensity for cytoskeletal alignment in response to fiber scaffolds with differing levels of anisotropy. The results indicated that valvular interstitial cells on moderately anisotropic substrates have a higher propensity for cytoskeletal alignment than cardiomyocytes and vascular endothelial cells. However, all cell types displayed similar levels of alignment on more extreme (isotropic and highly anisotropic) fiber scaffold organizations. These data suggest that in the hierarchy of signals that dictate the spatiotemporal organization of a tissue, geometric cues within the ECM and cellular networks may homogenize behaviors across cell populations and demographics.
This review explores the role of in vitro electrical and mechanical stimulation in modulating wound‐healing behavior, with a primary focus on the predominant skin cell types: fibroblasts and keratinocytes. By analyzing the existing literature, we delineate the complex relationships between stimulation parameters—such as voltage, current, frequency, and mechanical strain—and cellular responses, including proliferation and migration. Our data‐driven approach compiled more than 390 experimental data points for electrical stimulation and over 170 for mechanical stimulation in vitro, constructing a comprehensive library of cell responses that were previously fragmented and difficult to compare across studies. We critically evaluate various stimulation platforms and configurations, emphasizing their influence on cellular mechanobiology and their translational potential in regenerative medicine. Ultimately, this review underscores the necessity of a multi‐parameter optimization strategy to effectively exploit electromechanical cues for targeted skin tissue regeneration.
Testing cell viability in three-dimensional (3D) in vitro cell cultures is not always straightforward. Reduction-based metabolic assays have been suggested as a rapid, reportedly non-toxic mechanism for monitoring cell viability in continuous culture experiments. However, in 3D cultures these assays have been predominantly used semiquantitatively to indicate relative trends in viability. Obtaining quantitative values of cell number is often challenging, particularly when performing continuous measurements of viability when compared with end-point assessments. This work presents experiments performed to robustly identify and address the sources of inconsistency in existing Presto Blue™ methods for 3D cultures. Using human dermal fibroblasts (HDFs) as a model cell line seeded onto type I collagen scaffolds, we examine the impact of Presto Blue™ assays on reported cell numbers in 2D versus 3D cultures. We separate the impact of potential dye-induced toxicity from manipulation-induced cell detachment by considering the effects of passage number, incubation period, modifications of substrate chemistry and duration of total dye exposure as independent variables. The work presented includes a finalised protocol that demonstrates that while resazurin-based reduction assays remain a valuable tool for rapid assessment of cell metabolism and/or viability, additional considerations of the substrate and sampling frequencies are needed in 3D cultures to ensure accurate and reproducible results.